NCT05285735 Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants
| NCT ID | NCT05285735 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Amivas Inc. |
| Condition | Pregnancy |
| Study Type | OBSERVATIONAL |
| Enrollment | 25 participants |
| Start Date | 2022-06-08 |
| Primary Completion | 2029-06-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 25 participants in total. It began in 2022-06-08 with a primary completion date of 2029-06-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a prospective observational study in which a female patient who received IV Artesunate while pregnant can volunteer to provide information about her pregnancy and the outcome of her pregnancy. Information will be collected from patient's provider, the patient's obstetrician, the child's pediatrician, or other relevant healthcare provider.
Eligibility Criteria
Inclusion Criteria: * Patient received IV Artesunate * Patient was pregnant while receiving IV Artesunate * Patient was at least 15 years of age * Patient or legal guardian/representative gave consent for the study and to collect data from her physicians Exclusion Criteria • None
Contact & Investigator
Bryan Smith, MD
PRINCIPAL INVESTIGATOR
Amivas Inc.
Frequently Asked Questions
Who can join the NCT05285735 clinical trial?
This trial is open to female participants only, aged 15 Years or older, up to 100 Years, studying Pregnancy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05285735 currently recruiting?
Yes, NCT05285735 is actively recruiting participants. Contact the research team at kriggs@fastttrackresearch.com for enrollment information.
Where is the NCT05285735 trial being conducted?
This trial is being conducted at Piscataway, United States.
Who is sponsoring the NCT05285735 clinical trial?
NCT05285735 is sponsored by Amivas Inc.. The principal investigator is Bryan Smith, MD at Amivas Inc.. The trial plans to enroll 25 participants.